A Low-cost COVID-19 Vaccine Candidate
The supply of COVID-19 vaccine doses still lags behind the global demand for first-time vaccination and booster doses. Worldwide distribution of vaccine doses has been far from equitable, given the steep prices and logistical challenges that low- and middle-income countries face. I will present the development of a second-generation SARS-CoV-2 protein subunit vaccine candidate. We use protein engineering to enhance this candidate’s manufacturability, enabling global-scale manufacturing and distribution for LMICs.